Answers are grounded in this paper and cite their sources.
BACKGROUND: This meta-analysis was conducted to evaluate the effectiveness and safety of robot-assisted hepatectomy (RAH) versus open hepatectomy (OH) for liver tumors (LT). METHODS: A computer-based literature search was conducted to identify all randomized or nonrandomized controlled trials of RAH and OH in the treatment of LT from January 2000 to July 2022. Study-specific effect sizes and their 95% confidence intervals (CIs) were combined to calculate the pooled values, using a fixed-effects or random-effects model. RESULTS: Eight studies were included, with a combined total of 1079 patients. Compared with the OH group, the RAH group was found to involve less blood loss (standardized mean difference [SMD] = -152.52 mL; 95% confidence interval [CI] = -266.85 to 38.18; p = 0.009), shorter hospital stay (SMD = -2.79; 95% CI = -4.19 to -1.40; p < 0.001), a lower rate of postoperative complications (odds ratio [OR] =0.67; 95% CI = 0.47-0.95; p = 0.02), and a lower recurrence rate (OR = 0.42; 95% CI = 0.23-0.77; p = 0.005). However, operative time was longer in the RAH group than in the OH group (SMD = 70.55; 95% CI = 37.58-103.53; p < 0.001). CONCLUSION: This systematic review shows that RAH is safe and feasible in the treatment of LT.
No takes yet. Share an insight, caveat, or question.
Xuea et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: